Molecular Mechanisms of Cardiac Amyloidosis

Cardiac involvement has a profound effect on the prognosis of patients with systemic amyloidosis. Therapeutic methods for suppressing the production of causative proteins have been developed for ATTR amyloidosis and AL amyloidosis, which show cardiac involvement, and the prognosis has been improved....

Full description

Bibliographic Details
Main Authors: Yukihiro Saito, Kazufumi Nakamura, Hiroshi Ito
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/1/25
_version_ 1797498975733940224
author Yukihiro Saito
Kazufumi Nakamura
Hiroshi Ito
author_facet Yukihiro Saito
Kazufumi Nakamura
Hiroshi Ito
author_sort Yukihiro Saito
collection DOAJ
description Cardiac involvement has a profound effect on the prognosis of patients with systemic amyloidosis. Therapeutic methods for suppressing the production of causative proteins have been developed for ATTR amyloidosis and AL amyloidosis, which show cardiac involvement, and the prognosis has been improved. However, a method for removing deposited amyloid has not been established. Methods for reducing cytotoxicity caused by amyloid deposition and amyloid precursor protein to protect cardiovascular cells are also needed. In this review, we outline the molecular mechanisms and treatments of cardiac amyloidosis.
first_indexed 2024-03-10T03:40:58Z
format Article
id doaj.art-dce00a603ca54c55af808b88fb7fac68
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T03:40:58Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-dce00a603ca54c55af808b88fb7fac682023-11-23T11:33:21ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-12-012312510.3390/ijms23010025Molecular Mechanisms of Cardiac AmyloidosisYukihiro Saito0Kazufumi Nakamura1Hiroshi Ito2Department of Cardiovascular Medicine, Okayama University Hospital, Okayama 700-8558, JapanDepartment of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, JapanDepartment of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, JapanCardiac involvement has a profound effect on the prognosis of patients with systemic amyloidosis. Therapeutic methods for suppressing the production of causative proteins have been developed for ATTR amyloidosis and AL amyloidosis, which show cardiac involvement, and the prognosis has been improved. However, a method for removing deposited amyloid has not been established. Methods for reducing cytotoxicity caused by amyloid deposition and amyloid precursor protein to protect cardiovascular cells are also needed. In this review, we outline the molecular mechanisms and treatments of cardiac amyloidosis.https://www.mdpi.com/1422-0067/23/1/25amyloidcytotoxicitytransthyretinimmunoglobulin light chain
spellingShingle Yukihiro Saito
Kazufumi Nakamura
Hiroshi Ito
Molecular Mechanisms of Cardiac Amyloidosis
International Journal of Molecular Sciences
amyloid
cytotoxicity
transthyretin
immunoglobulin light chain
title Molecular Mechanisms of Cardiac Amyloidosis
title_full Molecular Mechanisms of Cardiac Amyloidosis
title_fullStr Molecular Mechanisms of Cardiac Amyloidosis
title_full_unstemmed Molecular Mechanisms of Cardiac Amyloidosis
title_short Molecular Mechanisms of Cardiac Amyloidosis
title_sort molecular mechanisms of cardiac amyloidosis
topic amyloid
cytotoxicity
transthyretin
immunoglobulin light chain
url https://www.mdpi.com/1422-0067/23/1/25
work_keys_str_mv AT yukihirosaito molecularmechanismsofcardiacamyloidosis
AT kazufuminakamura molecularmechanismsofcardiacamyloidosis
AT hiroshiito molecularmechanismsofcardiacamyloidosis